Abstract
Eggerthella lenta is an anaerobic, high GC, Gram-positive bacillus commonly found in the human digestive tract that belongs to the class Coriobacteriia of the phylum Actinobacteria. This species has been of increasing interest as an important player in the metabolism of xenobiotics and dietary compounds. However, little is known regarding its susceptibility to bacteriophage predation and how this may influence its fitness. Here, we report the isolation of seven novel E. lenta strains using cefotaxime and ceftriaxone as selective agents. We conducted comparative and pangenome analyses of these strains and those publicly available to investigate the diversity of prophages associated with this species. Prophage gene products represent a minimum of 5.8% of the E. lenta pangenome, comprising at least ten distantly related prophage clades that display limited homology to currently known bacteriophages. All clades possess genes implicated in virion structure, lysis, lysogeny and, to a limited extent, DNA replication. Some prophages utilise tyrosine recombinases and diversity generating retroelements to generate phase variation among targeted genes. The prophages have differing levels of sensitivity to the CRISPR/cas systems of their hosts, with spacers from 44 E. lenta isolates found to target only five out of the ten identified prophage clades. Furthermore, using a PCR-based approach targeting the prophage attP site, we were able to determine that several of these elements can excise from the host chromosome, thus supporting the notion that these are active prophages. The findings of this study provide further insights into the diversity of prophages infecting species of the phylum Actinobacteria.
Highlights
IntroductionThe human gastrointestinal tract hosts a wide variety of microorganisms (bacteria, archaea, yeasts, protists and viruses) capable of extending the metabolic capabilities of the human body, with bacterial numbers in the human gut estimated to be at 1011 CFU/g of faeces [1,2]
The human gastrointestinal tract hosts a wide variety of microorganisms capable of extending the metabolic capabilities of the human body, with bacterial numbers in the human gut estimated to be at 1011 CFU/g of faeces [1,2]
We devised a selective agar composition based on BHI++ media as described by Bisanz et al [27], supplemented with the broad-spectrum antibiotics cephalosporins ceftriaxone and cefotaxime as the bacterium has been reported to be highly resistant to both agents [18,70]
Summary
The human gastrointestinal tract hosts a wide variety of microorganisms (bacteria, archaea, yeasts, protists and viruses) capable of extending the metabolic capabilities of the human body, with bacterial numbers in the human gut estimated to be at 1011 CFU/g of faeces [1,2]. These organisms are capable of extending the metabolic potential of the human superorganism, playing an essential role in the digestion of polysaccharides, the synthesis of vitamins and amino acids, as well as the modification of endogenous compounds [3]. This is a Gram-positive, high GC, anaerobic, 4.0/)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.